scispace - formally typeset
C

Carlos Ortiz-Leyba

Researcher at University of Seville

Publications -  23
Citations -  2502

Carlos Ortiz-Leyba is an academic researcher from University of Seville. The author has contributed to research in topics: Intensive care & Intensive care unit. The author has an hindex of 14, co-authored 23 publications receiving 2382 citations.

Papers
More filters
Journal ArticleDOI

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

TL;DR: In patients admitted to the ICU for sepsis, the adequacy of initial empirical antimicrobial treatment is crucial in terms of outcome, although early mortality rate was unaffected by the appropriateness of empirical antibiotic therapy.
Journal ArticleDOI

Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients.

TL;DR: In critically ill septic patients, critical illness polyneuropathy significantly increases the duration of mechanical ventilation and prolongs the lengths of intensive care unit and hospital stays.
Journal ArticleDOI

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.

TL;DR: In critically ill patients with clinically suspected infection, treatment should be considered if features of pulmonary infection are present and Aspergillus spp.
Journal ArticleDOI

Risk Factors for Acinetobacter baumannii Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study

TL;DR: Risks that were independently associated with AB bacteremia were immunosuppression, unscheduled admission to the hospital, respiratory failure at ICU admission, previous antimicrobial therapy, previous sepsis in the ICU, and the invasive procedures index.
Journal ArticleDOI

Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study

TL;DR: Inadequate antimicrobial therapy at admission to the ICU with sepsis is associated with excess mortality and increases LOS, and a significant increment in duration of hospitalization in surviving pairs.